The U.S. Food and Drug Administration has approved a new non-hormonal treatment to help women manage menopause symptoms such as hot flashes and night sweats.
Elinzanetant (Lynkuet), a once-daily pill, is expected to be available within weeks.
These uncomfortable symptoms affect up to 80% of women during menopause and can last a decade or more, significantly affecting quality of life and sleep, The Menopause Society states.
For women seeking treatment who cannot safely take hormone therapy or are uncomfortable with it, this new option is another tool in the toolbox.
Related
